Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone Combined With Electroacupuncture and Ear Acupoint Pressing Beans for Refractory Cancer Pain
NCT07489625Phase 1Recruiting
- Sponsor
- Qinghai Red Cross Hospital
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hydromorphone in cancer pain, sponsored by Qinghai Red Cross Hospital. Primary endpoint: Numerical Rating Scale pain score at 2 weeks. Started Aug 2026; status: recruiting.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT07489625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07489625.